Difference between revisions of "Common Product Model"
Hbuitendijk (talk | contribs) |
Hbuitendijk (talk | contribs) |
||
Line 52: | Line 52: | ||
**Reconstitution Procedure - CPM24 | **Reconstitution Procedure - CPM24 | ||
***There is a variance between Gunther's original vs. the snippet in the proposal. | ***There is a variance between Gunther's original vs. the snippet in the proposal. | ||
− | ***Concerned that there | + | ***Concerned that there will be a possible ripple effect to other areas where Act is used in general, but not a concern here. |
***Motion to accept as proposed. Keith Thomas, Myron Finseth | ***Motion to accept as proposed. Keith Thomas, Myron Finseth | ||
****Against: 0; Abstain: 0; In Favor: 5 | ****Against: 0; Abstain: 0; In Favor: 5 | ||
− | ** | + | **Disease Qualifier - CPM25 |
+ | ***Where does it live in the model? In the clinical area with contraindications, indications, severity, frequency, etc. | ||
+ | ***There is another approach possibly using Coded Data type (CD) with qualifiers. | ||
===February 16, 2012=== | ===February 16, 2012=== |
Revision as of 14:24, 23 February 2012
This page will be used to discuss the content and publication of the Common Product Model.
Contents
Ambitions & Scope
The Common Product Model (CPM) will be an overarching domain information model relating to the HL7 v3 modeling of any kind (or instance) of a 'product'. The definition of the term product is intentionally kept loose at this point, but will definitely include:
- Medication, incl. vaccines
- Devices used in medical services
- Anything else a person can be exposed to
The CPM is set up as a joint initiative within HL7 project, 'sponsored' by the O&O work group.
The following stakeholders have been identified:
- Pharmacy (for Medication and possibly for devices)
- Patient Safety (for Individual Case Safety Reports)
- RCRIM (for Structured Product Labeling, Regulated Product Submissions, and Drug Product Stability)
- PHER (for vaccines used in Immunization)
Storyboards
This space will list a number of storyboards that relate to the different perspectives on what a product is and how it is used.
These storyboards are divided into groups:
- Pharmacy related storyboards
- ICSR related storyboards
- SPL related storyboards
- Regulated Product Submission Release 2 (RPS R2) Storyboards (not specific to CPM)
- Immunization related storyboards
Governance
CPM Governance as adopted during the San Diego WGM Sept 2011
The SVN repository is at http://gforge.hl7.org/svn/hl7v3/trunk/cpm
CPM Technical Corrections
Details of Current Technical Corrections and Archived Technical Corrections can be found on separate pages by clicking on the links below.
Archived CPM Technical Corrections
Meeting Minutes
February 23, 2012
Attendees: Gunther Schadow, Keith Thomas, Hans Buitendijk, Julie James, Myron Finseth, Hugh Glover
- Harmonization Proposals
- Reconstitution Procedure - CPM24
- There is a variance between Gunther's original vs. the snippet in the proposal.
- Concerned that there will be a possible ripple effect to other areas where Act is used in general, but not a concern here.
- Motion to accept as proposed. Keith Thomas, Myron Finseth
- Against: 0; Abstain: 0; In Favor: 5
- Disease Qualifier - CPM25
- Where does it live in the model? In the clinical area with contraindications, indications, severity, frequency, etc.
- There is another approach possibly using Coded Data type (CD) with qualifiers.
- Reconstitution Procedure - CPM24
February 16, 2012
Attendees: Hugh Glover, Gunther Schadow, Myron Finseth, Keith Thomas, Hans Buitendijk, Rob Savage
- Agenda:
- How to tie IDMP back to CPM
- Harmonization Proposals (9 total - 3 a week)
- Technical Corrections
- IDMP to CPM
- So far we grew CPM to cover IDMP, but is becoming unwieldy.
- Primary objection/concerns that if you unroll CPM people get schemas that are new to them.
- Present CPM with CMETs, but include guidance on where things for IDMP, how to thread it together, serialization.
- Should that information in CPM or IDMP implementation documentation? Should be in IDMP documentation.
- We're reviewing it here as there will be adjustments likely.
- IDMP is on same May Ballot Cycle.
- Harmonization Proposals
- Combined Dose Form Concept Domain - CPM-21
- File:Combined Dose Form.doc
- Motion to accept as proposed. Hugh Glover, Rob Savage Against: 0; Abstain: 0; In Favor: 4
- Material Form - CPM-22
- File:Material Form.doc
- Concern that this cannot be put above Material. A Combined Dose Form could consist of multiple materials of different forms.
- Suggest to carry into OO discussion in next 2 weeks.
- Container Form Concept Definition - CPM-23
- File:Container Form.doc
- Motion to accept as is. Gunther Schadow, Hugh Glover. Against: 0; Abstain: 0; In Favor: 4
- Combined Dose Form Concept Domain - CPM-21
- RIM Proposals
- Contaminant is an Ingredient
- File:RoleClass Contaminant is an Ingredient.doc
- Motion to accept as is. Gunther Schadow, ??. • Against: 0; Abstain:0; In Favor: 4
- Living Subject
- File:Living Subject.doc
- Not yet discussed. Next week
- Contaminant is an Ingredient